<table id="ID630" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 13. Established and Other Potentially Significant Drug Interactions</caption>
<col width="30%"></col>
<col width="24%"></col>
<col width="46%"></col>
<tfoot>
<tr>
<td align="left" colspan="3">
<paragraph stylecode="Footnote">↓ = Decreased (induces lamotrigine glucuronidation). <br/>
</paragraph>
</td>
</tr>
<tr>
<td align="left" colspan="3">
<paragraph stylecode="Footnote">↑ = Increased (inhibits lamotrigine glucuronidation). <br/>
</paragraph>
</td>
</tr>
<tr>
<td align="left" colspan="3">
<paragraph stylecode="Footnote">? = Conflicting data. <br/>
</paragraph>
</td>
</tr>
</tfoot>
<tbody>
<tr>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="bottom">
<content stylecode="bold">Concomitant </content>
<content stylecode="bold">Drug</content>
<content stylecode="bold">
<br/>
</content>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<content stylecode="bold">Effect </content>
<content stylecode="bold">on</content>
<content stylecode="bold">
<br/>
</content>
<content stylecode="bold"> </content>
<content stylecode="bold">Concentration </content>
<content stylecode="bold">of</content>
<content stylecode="bold">
<br/>
</content>
<content stylecode="bold"> </content>
<content stylecode="bold">Lamotrigine </content>
<content stylecode="bold">or</content>
<content stylecode="bold">
<br/>
</content>
<content stylecode="bold"> </content>
<content stylecode="bold">Concomitant </content>
<content stylecode="bold">Drug</content>
<content stylecode="bold">
<br/>
</content>
</td>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<content stylecode="bold">
<br/>
</content>
<content stylecode="bold">
<br/>
</content>
<content stylecode="bold">
<br/>
</content>
<content stylecode="bold">Clinical </content>
<content stylecode="bold">Comment</content>
<content stylecode="bold">
<br/>
</content>
</td>
</tr>
<tr>
<td align="justify" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Estrogen-containing oral<br/> contraceptive preparations<br/> containing 30 mcg<br/> ethinylestradiol and 150 mcg <br/>levonorgestrel <br/>
</td>
<td align="justify" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓ lamotrigine<br/>
<br/>↓ levonorgestrel <br/>
<br/>
</td>
<td align="justify" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Decreased lamotrigine concentrations<br/>approximately 50%.<br/>Decrease in levonorgestrel component by 19%. <br/>
</td>
</tr>
<tr>
<td align="justify" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Carbamazepine and<br/> carbamazepine epoxide <br/>
<br/>
</td>
<td align="justify" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓ lamotrigine <br/>
<br/>? carbamazepine<br/> epoxide <br/>
</td>
<td align="justify" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Addition of carbamazepine decreases<br/>lamotrigine concentration approximately 40%. <br/>May increase carbamazepine epoxide levels. <br/>
</td>
</tr>
<tr>
<td align="justify" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Lopinavir/ritonavir <br/>
<br/>
</td>
<td align="justify" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓ lamotrigine <br/>
<br/>
</td>
<td align="justify" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Decreased lamotrigine concentration<br/>approximately 50%. <br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Atazanavir/ritonavir<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓ lamotrigine<br/>
</td>
<td align="justify" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Decreased lamotrigine AUC<br/>approximately 32%.<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Phenobarbital/primidone<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓ lamotrigine<br/>
</td>
<td align="justify" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Decreased lamotrigine concentration<br/>approximately 40%.<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Phenytoin<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓ lamotrigine<br/>
</td>
<td align="justify" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Decreased lamotrigine concentration<br/>approximately 40%.<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Rifampin<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↓ lamotrigine<br/>
</td>
<td align="justify" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Decreased lamotrigine AUC approximately<br/>40%.<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<br/>Valproate                             <br/>
<br/>
<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">↑ lamotrigine<br/>
<br/>? valproate<br/>
<br/>
</td>
<td align="justify" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Increased lamotrigine concentrations slightly<br/>more than 2-fold.<br/>There are conflicting study results regarding<br/>effect of lamotrigine on valproate<br/>concentrations: 1) a mean 25% decrease in<br/>valproate concentrations in healthy volunteers,<br/>2) no change in valproate concentrations in<br/>controlled clinical trials in patients with<br/>epilepsy.<br/>
</td>
</tr>
</tbody>
</table>